Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study.
Kar
P
P
Chandrashekar
N
N
Devi
S
S
Bhatia
Shobna J
SJ
Alvares
J F F
JF
Taneja
A
A
Towar
A
A
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D004942:Esophagitis, Peptic / Q000188:drug therapy; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D015337:Multicenter Studies as Topic; D009853:Omeprazole / Q000031:analogs & derivatives; D054328:Proton Pump Inhibitors; D017494:Proton Pumps / Q000627:therapeutic use*; D064750:Rabeprazole; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D017494:Proton Pumps; D064750:Rabeprazole; D009853:Omeprazole